White Cloud Mountain (600332.SH) subsidiary Children's Xiao Chai Hu Granules entered Phase II clinical trial.

Wisdom Financial News APP News, Baiyunshan (600332.SH) announced that its subsidiary Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. ("Guanghua Pharmaceutical") recently disclosed the registration information of Phase II clinical trials of children's Xiaochaihu particles developed by Guanghua Pharmaceutical on the drug clinical trial registration and information disclosure platform of the National Medical Products Administration.